WASHINGTON — House lawmakers urged the Food and Drug Administration on Tuesday to quickly finalize rules governing the growing field of health-care apps, including clarifying whether the industry will be subject to new taxes under the Affordable Care Act.
Consumers already use the apps to track blood sugar levels and weight loss, which they can share with their doctors. But regulators are struggling to determine when the apps turn smartphones and tablets into a medical device subject to additional regulations.
The FDA has been mulling over these issues for years, releasing a proposal in 2011 that gave it wider authority over apps that duplicate the functions of existing medical devices, such as apps that show MRI scans or measure heart rates.
But the agency has yet to issue final guidance on the matter and declined to comment on the latest push from Congress.
Now lawmakers are questioning whether defining the apps as medical devices subjects them to new taxes under the Affordable Care Act.
"Most Americans have no idea that their smartphone, tablet or the mobile apps that have become part of their daily lives could be subject to added red tape or a new tax under Obamacare," Energy and Commerce Committee Chairman Fred Upton, R-Mich., said in a statement.
The committee will hold three hearings next week to put further pressure on the FDA to take action. The hearings will examine how FDA regulations could affect patients, physicians and developers looking to capitalize on the growing field.
The FDA's progress on the issue has been watched closely by privacy advocates concerned about how the agency would balance the potential medical benefits of the apps against the privacy concerns of having such sensitive data in the hands of the private companies that develop the software.
The market for health-related apps has been growing for years. Mobile health apps and accessories are expected to reach $26 billion in sales by 2017, up from $718 million in 2011, according to Research2Guidance, a consulting firm.